Sanara MedTech Inc. (SMTI)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Sanara MedTech Inc. (SMTI) is down 9.0% since the beginning of the year. At $21 per share, SMTI is trading 40.9% below its 52-week high of $36. Investors who bought $1,000 worth of SMTI shares 5 years ago would now be looking at an investment worth $711.

Sanara MedTech Inc. (SMTI) has returned -8.95% so far this year and -26.92% over the past 12 months. Over the last decade, SMTI has posted an annualized return of 14.07%, slightly higher than the S&P 500 Index benchmark’s 13.75%.

Based on dividend-adjusted daily data since Feb 22, 2011, SMTI's average daily return is +0.29%, while the average monthly return is +1.70%. At this rate, an investment would double in approximately 3.4 years.

Historically, 45% of months were positive and 55% were negative. The best month was Jan 2019 with a return of +83.8%, while the worst month was Feb 2020 at -44.4%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 6 months.

On a daily basis, SMTI closed higher 37% of trading days. The best single day was Jul 16, 2012 with a return of +109.5%, while the worst single day was May 10, 2019 at -45.0%.

Sanara MedTech Inc. has an annualized alpha of 89.61%, beta of 0.60, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since February 23, 2011.

• This stock participated in 159.82% of S&P 500 Index downside but only 78.26% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.60 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

SMTI ranks 23 for risk / return — below 23% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for Sanara MedTech Inc. (SMTI) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Sanara MedTech Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Sanara MedTech Inc. was 97.48%, occurring on Dec 10, 2018. The portfolio has not yet recovered.

The current Sanara MedTech Inc. drawdown is 73.26%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Sanara MedTech Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Sanara MedTech Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.